Recent advances in the research of an endemic osteochondropathy in China: Kashin-Beck disease

Osteoarthritis and Cartilage

Volumn 22, Issue 11, 2014, Pages 1774-1783

  Guo, X ^a   Ma, W J ^a   Zhang, F ^a   Ren, F L ^a   Qu, C J ^b   Lammi, M J ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cartilage; Gene expression; Kashin Beck disease; Osteochondropathy; Proteomics

Indexed keywords

DRINKING WATER; TRACE ELEMENT;

BLOUNT DISEASE; CHINA; DIET SUPPLEMENTATION; ENDEMIC DISEASE; GENE EXPRESSION PROFILING; HUMAN; KASHIN BECK DISEASE; PREVALENCE; PROTEOMICS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; GENETICS; INCIDENCE; KASHIN-BECK DISEASE; MEDICAL RESEARCH; PROCEDURES;

BIOMEDICAL RESEARCH; CHINA; ENDEMIC DISEASES; HUMANS; INCIDENCE; KASHIN-BECK DISEASE; PROTEOMICS;

EID: 84908237450     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.07.023     Document Type: Review

References (78)

1. Allander E. Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand J Rheumatol Suppl 1994, 99:1-36.
2. P.R.C.Ministry of Health The prevention and control status of Kaschin-Beck disease in 2011 2012, Available at:. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.html.
3. Guo X. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 2001, 25:147-150.
4. Peng A., Yang C., Rui H., Li H. Study on the pathogenic factors of Kashin-Beck disease. JToxicol Environ Health 1992, 35:79-90.
5. Zhang B., Yang L., Wang W., Li Y., Li H. Environmental selenium in the Kaschin-Beck disease area, Tibetan Plateau, China. Environ Geochem Health 2011, 33:495-501.
6. Sokoloff L. The history of Kashin-Beck disease. NY State J Med 1989, 89:343-351.
7. Zhang G.Q., Liu J.X., Yu J.Y., Shi Y.X., Zhang S.J. Ultrastructure of chondrocytes in articular cartilage of Kashin-Beck disease. Chin J Endemiol 1989, 8:27-30.
8. Guo X., Zuo H., Cao C.X., Zhang Y., Geng D., Zhang Z.T., et al. Abnormal expression of Col X, PTHrP, TGF-beta, bFGF, and VEGF in cartilage with Kashin-Beck disease. JBone Miner Metab 2006, 24:319-328.
9. Wang W., Guo X., Chen J., Xu P., Lammi M.J. Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease. JRheumatol 2008, 35:696-702.
10. Wang S.J., Guo X., Zuo H., Zhang Y.G., Xu P., Ping Z.G., et al. Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease. JRheumatol 2006, 33:615-619.
11. Zhang B.D., Guo X., Bai G.K., Ping Z.G., Zuo H., Ren F.L., et al. The changes of nitric oxide, NO synthase, and sFas/Apo-1 in serum among the patients with Kashin-Beck disease. Chin J Endemiol 2004, 31:172-175.
12. Li S., Cao J., Caterson B., Hughes C.E. Proteoglycan metabolism, cell death and Kashin-Beck disease. Glycoconj J 2012, 29:241-248.
13. Cao J., Li S., Shi Z., Yue Y., Sun J., Chen J., et al. Articular cartilage metabolism in patients with Kashin-Beck disease: an endemic osteoarthropathy in China. Osteoarthritis Cartilage 2008, 16:680-688.
14. Tang X., Zhou Z., Shen B., Yang J., Kang P., Li J., et al. Serum levels of TNF-alpha, IL-1beta, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China. Rheumatol Int 2012, 32:3503-3509.
15. Dong W., Zhang Y., Liu H., Gao B., Li D., Yang J. Detection of unsaturated disaccharides, pyridinoline, and hydroxyproline in urine of patients with Kashin-Beck disease: comparison with controls in an endemic area. JRheumatol 2009, 36:816-821.
16. Tian L., Wang W., Hou W., Tian J., Zhong N., Sun J., et al. Autoimmune and inflammatory responses in Kashin-Beck disease compared with rheumatoid arthritis and osteoarthritis. Hum Immunol 2011, 72:812-816.
17. Li S., Xiao T., Zheng B. Medical geology of arsenic, selenium and thallium in China. Sci Total Environ 2012, 421-422:31-40.
18. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., et al. Characterization of mammalian selenoproteomes. Science 2003, 300:1439-1443.
19. Downey C.M., Horton C.R., Carlson B.A., Parsons T.E., Hatfield D.L., Hallgrimsson B., et al. Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet 2009, 5:e1000616.
20. Bosl M.R., Takaku K., Oshima M., Nishimura S., Taketo M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci USA 1997, 94:5531-5534.
21. Mo D.X., Ding D.X., Wang Z.L., Zhang J.J. Study on relationship between selenium and Kashin-Beck disease in 20 years. Chin J Contr Endem Dis 1997, 12:18-21.
22. Moreno-Reyes R., Mathieu F., Boelaert M., Begaux F., Suetens C., Rivera M.T., et al. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003, 78:137-144.
23. Ren F.L., Guo X., Zhang R.J., Wang S., Zuo H., Zhang Z.T., et al. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats. Osteoarthritis Cartilage 2007, 15:1171-1177.
24. Ma J.J. Experimental observation of effects of sodium silicate on monkey. A study on the pathogenesis of Kaschin-Beck disease. Chin J Contr Endem Dis 1984, 83-87.
25. Yuan S.N., Mo D.X. Histopathological, autoradiographical and biochemical on thallium chondronecrosis and its alleviation by sodium selenite. Zhonghua Bing Li Xue Za Zhi 1987, 16:206-209.
26. Zhang G.Q., Li C.F., Li L.Q., Liu J.X., Sun K., Zhang H.X., et al. Thallium-caused band-like necrosis of the chondrocytes in hypertrophic zones of the epiphyseal plate in monkey. End Dis Bull 1987, 2:40-41.
27. Tian J., Yan J., Wang W., Zhong N., Tian L., Sun J., et al. T-2 toxin enhances catabolic activity of hypertrophic chondrocytes through ROS-NF-κB-HIF-2α pathway. Toxicol InVitro 2012, 26:1106-1113.
28. Li S.Y., Cao J.L., Shi Z.L., Chen J.H., Zhang Z.T., Hughes C.E., et al. Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. JZhejiang Univ Sci B 2008, 9:22-33.
29. Shi Z., Cao J., Chen J., Li S., Zhang Z., Yang B., et al. Butenolide induced cytotoxicity by disturbing the prooxidant-antioxidant balance, and antioxidants partly quench in human chondrocytes. Toxicol InVitro 2009, 23:99-104.
30. Zhang G.Q., Liu J.X. An experimental animal model of Kashin-Beck disease. Ann Rheum Dis 1989, 48:149-152.
31. Guo X., Lammi M., Aigner T., Lammi P., Vornehm S., Yu Z.D., et al. Effect of low selenium on chondrocyte differentiation and differential expression of collagen types I, II, and X mRNA in articular cartilage from mini-pigs. JXi'an Med Univ 2000, 12:108-112.
32. Guan F., Li S., Wang Z.L., Yang H., Xue S., Wang W., et al. Histopathology of chondronecrosis development in knee articular cartilage in a rat model of Kashin-Beck disease using T-2 toxin and selenium deficiency conditions. Rheumatol Int 2012, 33:157-166.
33. Yao Y.F., Kang P.D., Li X.B., Yang J., Shen B., Zhou Z.K., et al. Study on the effect of T-2 toxin combined with low nutrition diet on rat epiphyseal plate growth and development. Int Orthop 2010, 34:1351-1356.
34. Yan D., Kang P., Li Y., Yang J., Shen B., Zhou Z., et al. Radiographic findings of Wistar rats fed with T-2 toxin and Kashin-Beck disease-affected diet. Int J Rheum Dis 2011, 14:92-97.
35. Chen J.H., Xue S., Li S., Wang Z.L., Yang H., Wang W., et al. Oxidant damage in Kashin-Beck disease and a rat Kashin-Beck disease model by employing T-2 toxin treatment under selenium deficient conditions. JOrthop Res 2012, 30:1229-1237.
36. Ping Z.G., Guo X., Wang F.Q., Wang Z.W. Epidemiological characters of Kashin-Beck disease in nuclear families. Chin J Epidemiol 2004, 25:848-851.
37. Zhang Y., Guo X., Ping Z., Yu M., Shi X., Lv A., et al. Main source of drinking water and familial aggregation of Kashin-Beck disease: a population based on case-control family study. Ann Epidemiol 2009, 19:560-566.
38. Valdes A.M., Spector T.D. The contribution of genes to osteoarthritis. Med Clin North Am 2009, 93:45-66.
39. Shi X.W., Guo X., Lü A.L., Kang L., Zhou Y.L., Zhang Y.Z., et al. Heritability estimates and linkage analysis of 23 short tandem repeat loci on chromosomes 2, 11, and 12 in an endemic osteochondropathy in China. Scand J Rheumatol 2010, 39:259-265.
40. Shi X.W., Guo X., Ren F.L., Li J., Wu X.M. The effect of short tandem repeat loci and low selenium levels on endemic osteoarthritis in China. JBone Joint Surg Am 2010, 92:72-80.
41. Kang L.L., Guo X., Zuo H., Ping Z.G., Zhang B.D., Lai J.H., et al. Analysis of allele frequencies of 7 short tandem repeat loci of Kashin-Beck disease patients on chromosome 12. Chin J Epidemiol 2005, 26:790-793.
42. Lü A.L., Guo X., Shi X.W., Ren F.L. Association of genetic polymorphism of 14 STR loci on chromosome 2 with Kashin-Beck disease. JSichuan Univ Med Sci Ed 2011, 42:29-31.
43. Zuo H., Guo X., Kang L.L., Ping Z.G., Zhang B.D., Wang S.J., et al. Analysis of allele frequencies of 6 short tandem repeat loci on chromosome 12 in patients with Kashin-Beck disease. JSouth Med Univ 2006, 26:414-417.
44. Demissie S., Cupples L.A., Myers R., Aliabadi P., Levy D., Felson D.T. Genome scan for quantity of hand osteoarthritis: the Framingham Study. Arthritis Rheum 2002, 46:946-952.
45. Gao X.Y., Zhou Y.L., Yu M., Tu Q.Q., Wu L.N., Lai J.H., et al. Association between GDF5 gene polymorphism and Kashin-Beck disease. JXi'an Jiaotong Univ Med Sci 2010, 31:501-504.
46. Yu M., Guo X., Gao X.Y., Lai J.H., Tu Q.Q. Association between polymorphism in DVWA and IL-1beta and Kashin-Beck disease. JSichuan Univ Med Sci Ed 2010, 41:669-673.
47. Du X.H., Dai X.X., Xia Song R., Zou X.Z., Yan Sun W., Mo X.Y., et al. SNP and mRNA expression for glutathione peroxidase 4 in Kashin-Beck disease. Br J Nutr 2012, 107:164-169.
48. Xiong Y.M., Mo X.Y., Zou X.Z., Song R.X., Sun W.Y., Lu W., et al. Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease. Osteoarthritis Cartilage 2010, 18:817-824.
49. Zhao Q.M., Guo X., Lai J.H., Tan W.H., Wang W.Z., Dang X.Q. Association of TNF-alpha and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population. Clin Rheumatol 2012, 31:1051-1057.
50. Sun W., Wang X., Zou X., Song R., Du X., Hu J., et al. Selenoprotein P gene r25191g/a polymorphism and quantification of selenoprotein P mRNA level in patients with Kashin-Beck disease. Br J Nutr 2010, 104:1283-1287.
51. Shi Y., Lu F., Liu X., Wang Y., Huang L., Liu X., et al. Genetic variants in the HLA-DRB1 gene are associated with Kashin-Beck disease in the Tibetan population. Arthritis Rheum 2011, 63:3408-3416.
52. Yang Z., Xu Y., Luo H., Ma X., Wang Q., Wang Y., et al. Whole-exome sequencing for the identification of susceptibility genes of Kashin-Beck disease. PLoS One 2014, 9:e92298.
53. Zhang F., Guo X., Zhang Y., Wen Y., Wang W., Wang S., et al. Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease. Hum Genet 2014, 133:793-799.
54. Wang W.Z., Guo X., Duan C., Ma W.J., Zhang Y.G., Xu P., et al. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthritis Cartilage 2009, 17:83-90.
55. Wu C., Lei R., Tiainen M., Wu S., Zhang Q., Pei F., et al. Disordered glycometabolism involved in pathogenesis of Kashin-Beck disease, an endemic osteoarthritis in China. Exp Cell Res 2014, Epub ahead of print. 10.1016/j.yexcr.2014.04.019.
56. Wang S., Guo X., Wang W., Wang S. Genome-wide study identifies the regulatory gene networks and signaling pathways from chondrocyte and peripheral blood monocyte of Kashin-Beck disease. Genes Cells 2012, 17:619-632.
57. Han J., Guo X., Tan W., Zhang F., Liu J., Wang W., et al. The expression of p-ATF2 involved in the chondeocytes apoptosis of an endemic osteoarthritis, Kashin-Beck disease. BMC Musculoskelet Disord 2013, 14:209.
58. Zhang F., Guo X., Wang W., Yan H., Li C. Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease. PLoS One 2011, 6:e22983.
59. Li C., Wang W., Guo X., Zhang F., Ma W., Zhang Y., et al. Pathways related to mitochondrial dysfunction in cartilage of endemic osteoarthritis patients in China. Sci China Life Sci 2012, 55:1057-1063.
60. Wang S., Guo X., Wu X.M., Lammi M.J. Genome-wide gene expression analysis suggests an important role of suppressed immunity in pathogenesis of Kashin-Beck disease. PLoS One 2012, 7:e28439.
61. Zhang F., Guo X., Wang W., Wu S., Ma W., Yan H. Expression profile analysis of mycotoxin-related genes in cartilage with endemic osteochondropathy Kashin-Beck disease. BMC Musculoskelet Disord 2012, 13:130.
62. Duan C., Guo X., Zhang X.D., Yu H.J., Yan H., Gao Y., et al. Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. Arthritis Rheum 2010, 62:771-780.
63. Zheng J., Wu C., Ma W., Zhang Y., Hou T., Xu H., et al. Abnormal expression of chondroitin sulphate N-acetylgalactosaminyltransferase 1 and Hapln-1 in cartilage with Kashin-Beck disease and primary osteoarthritis. Int Orthop 2013, 37:2051-2059.
64. Luo M., Chen J., Li S., Sun H., Zhang Z., Fu Q., et al. Changes in the metabolism of chondroitin sulfate glycosaminoglycans in articular cartilage from patients with Kashin-Beck disease. Osteoarthritis Cartilage 2014, 22:986-995.
65. Zhang F., Guo X., Duan C., Wu S., Yu H., Lammi M. Identification of differentially expressed genes and pathways between primary osteoarthritis and endemic osteoarthritis (Kashin-Beck disease). Scand J Rheumatol 2013, 42:71-79.
66. Wu S.X., Wang W.Z., Zhang F., Wu C.Y., Dennis B.S., Qu C.J., et al. Expression profiles of genes involved in apoptosis and selenium metabolism in articular cartilage of patients with Kashin-Beck osteoarthritis. Gene 2014, 535:124-130.
67. Wang W., Wei S., Luo M., Yu B., Cao J., Yang Z., et al. Oxidative stress and status of antioxidant enzymes in children with Kashin-Beck disease. Osteoarthritis Cartilage 2013, 21:1781-1789.
68. Liu J.T., Guo X., Ma W.J., Zhang Y.G., Xu P., Yao J.F., et al. Mitochondrial function is altered in articular chondrocytes of an endemic osteoarthritis, Kashin-Beck disease. Osteoarthritis Cartilage 2010, 18:1218-1226.
69. Wang S., Guo X., Tan W.H., Geng D., Deng B.P., Wang C.E., et al. Detection of serum proteomic changes and discovery of serum biomarkers for Kashin-Beck disease using surface-enhanced laser desorption ionization mass spectrometry (SELDI-TOF MS). JBone Miner Metab 2008, 26:385-393.
70. Ma W.J., Guo X., Liu J.T., Liu R.Y., Hu J.W., Sun A.G., et al. Proteomic changes in articular cartilage of human endemic osteoarthritis in China. Proteomics 2011, 11:2881-2890.
71. Zou K., Liu G., Wu T., Du L. Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthritis Cartilage 2009, 17:144-151.
72. Jirong Y., Huiyun P., Zhongzhe Y., Birong D., Weimin L., Ming Y., et al. Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials. Osteoarthritis Cartilage 2012, 20:605-613.
73. Xu G.Y., Lü X.Y., Cao X.G. Analysis on monitoring data of Kaschin-Beck disease in Shaanxi province during 19 years. Chin J Contr End Dis 2009, 24:442-446.
74. Xu P., Guo X., Jin W.Z., Yao J.F., Wang J.H., Zhang Y.G. The curative effects of intra-knee joint injections of sodium hyaluronate to treat Kashin-Beck disease. Chin J Contr Endem Dis 2004, 23:588-590.
75. Yue J., Yang M., Yi S., Dong B., Li W., Yang Z., et al. Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study. Osteoarthritis Cartilage 2012, 20:622-629.
76. Tang X., Pei F.X., Zhou Z.K., Liu G., Shen B., Kang P.D., et al. Arandomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee. Clin Rheumatol 2012, 31:1079-1086.
77. Tang X., Zhou Z.K., Liu G., Shen B., Kang P.D., Li J., et al. The long-term efficacy and tolerability of hyaluronic acid in adult patients with Kashin-Beck disease of the knee. Clin Rheumatol 2014, Published online, http://dx.doi.org/10.1007/s10067-014-2519-0.
78. Yu F.F., Xia C.T., Fang H., Han J., Younus M.I., Guo X. Evaluation of the therapeutic effect of treatment with intra-articular hyaluronic acid in knees for Kashin-Beck disease: a meta-analysis. Osteoarthritis Cartilage 2014, 22:718-725.